CMR findings in asymptomatic male HIV patients compared to healthy male controls

Background The increased survival associated with the advent of antiretroviral therapy (ART) for HIV in the mid-1990s has been accompanied by an increase in cardiovascular comorbidity and mortality. Atherothrombosis, myocardial disease, hypertension, diabetes, and pulmonary hypertension have been identified as entities associated with treated disease and the risk of major cardiovascular events is higher than in the uninfected population. HIV patients on ART are at higher risk of developing left ventricular (LV) systolic dysfunction, and more recent studies have additionally demonstrated significantly higher levels of diastolic dysfunction and LV hypertrophy to controls.